Join us for Curebound Night at the Ballpark June 21. $10 from every ticket purchase goes back to Curebound. Tickets here.

[object Object],[object Object]

THE POWER OF
COLLABORATION

The best ideas happen when the right people work together.

Curebound
Curebound

CUREBOUND RESEARCH PROGRAM

COLLABORATIVE PARTNERS + INVESTMENT PILLARS

Collaboration is at the center of Curebound’s unique grantmaking platform. All Curebound grants demand collaboration among specialized teams from our research partner institutions, enabling the brightest minds from different scientific disciplines to work together to produce better options and outcomes for patients. Curebound's institutional research partners include:

  • Moores Cancer Center at UC San Diego Health
  • Salk Institute
  • Sanford-Burnham Prebys
  • Rady Children’s Hospital
  • La Jolla Institute for Immunology
  • Scripps Research

Curebound funds promising, innovative oncology research for all types of cancer, adult and pediatric, in alignment with five scientific investment pillars:

  • Prevention and diagnostic tools
  • Novel approaches and new therapeutic platforms
  • Immunotherapies and personalized vaccines
  • Cancer equities
  • Pediatric cancers

All grant submissions undergo rigorous peer review and are held to the strictest standards of scientific excellence.

Curebound is committed to supporting the most exciting projects in cancer research at all stages including work that is ready to make the transition to commercialization and patient application. Catalyst Grant funding is available for San Diego based early-stage biotech companies to conduct research that addresses critical challenges in cancer prevention, detection, and treatment and demonstrates opportunity to advance swiftly to clinic. To learn more about the Catalyst Grant program, please read on below.

CUREBOUND GRANTS

Curebound funds five types of cancer research grants. Please click below for detailed information on each grant type and contact the Grants Department with any questions at research@curebound.org

Discovery Grants

One-time seed grants of up to $250,000 for high-risk/high-reward, research that requires inter-institutional collaboration. Ideas are innovative and in the early phases where smaller grants can make a big impact in advancing research.

Targeted Grants

Larger awards of $500,000 that aim to fund projects that are closer to clinical stages. Targeted Grants require interdisciplinary collaboration in order to ensure the project is geared toward translational application.

Cure Prizes

Innovative, multi-disciplinary projects that receive major funding of $1,000,000 to be administered over multiple years. The Cure Prize challenge is to develop an innovation that will improve the standard of care for a typically deadly cancer with patient application in 3-5 years.

Equity Grants


Awards funding of up to $250,000 for research that directly addresses cancer-related health disparities and positively impacts outcomes in underrepresented or underserved populations.

Catalyst Grants

Catalyst Grants award funds of up to $250,000 to early-stage companies to conduct innovative oncology-based research that holds promise for rapid translation to the clinic.

Curebound
Curebound

GRANT APPLICATIONS

The 2024 Letter of Intent (LOI) process for Equity Grants and Catalyst Grants is open January 8 - April 2. Discovery Grants, Targeted Grants, and Cure Prizes LOIs are open April 16 - May 14. To be eligible to receive funding, applicants must submit a LOI through Curebound's submission platform, Proposal Central, which can be accessed via the link below.

If you have any questions regarding the form or process, please contact research@curebound.org.

2024 Discovery Grant, Targeted Grant and Cure Prize Grant Process Timeline:

April 16, 2024: LOI open

May 14, 2024: LOI due

June 11, 2024: Selected applicants are invited to apply

July 30, 2024: Full applications due

December, 2024: Applicants notified

2024 Equity Grant and Catalyst Grant Process Timeline:

January 8, 2024: LOI open

April 2, 2024: LOI due

April 12, 2024: Selected applicants are invited to apply

May 14: Full applications due

August, 2024: Applicants notified

Institutional Research Grant Eligibility: (Catalyst Applicants Excluded)

Team Leaders (Principal Investigator) must hold a faculty position at one of the following institutes:

UC San Diego*
Salk Institute
Sanford Burnham Prebys
Rady Children’s Hospital
La Jolla Institute for Immunology
Rady Children’s Hospital
Scripps Research

*Includes UC San Diego Health and affiliated institutions i.e., Moores Cancer Center, San Diego State University, and J. Craig Venter Institute.

View the 2023 Research Portfolio.

APPLY FOR CUREBOUND GRANT FUNDING

RESEARCH PORTFOLIO

Curebound raises and invests strategic funding in translational cancer research projects aimed at accelerating new discoveries to clinical application. The full index of our research portfolio is available below.

FILTER BY

Curebound
Curebound

*Founders Bill & Amy Koman, Cure Prize Recipients Rebecca Rakow-Penner MD, PhD (UCSD), Michael McHale MD (UCSD), CEO Anne Marbarger*

*Not pictured: Anders Dale PhD (UCSD)*

CURE PRIZE

The Cure Prize is Curebound’s highest award for bold innovation in cancer research, recognizing Innovative, multi-disciplinary projects that receive major funding of $1,000,000+ to be administered over multiple years. The first Cure Prize challenge was to develop an innovation that will improve the standard of care for a typically deadly cancer with patient application in 3-5 years.

In June, 2022 Curebound awarded its first Cure Prize:

2023 Cure Prize: Screening for Ovarian Cancer with Advanced Diffusion MRI in Patients at High Risk for Ovarian Cancer
In Honor of the Koman Family

Scientists: Rebecca Rakow-Penner MD, PhD, Anders Dale, PhD, Michael McHale, MD (UC San Diego)

Ovarian cancer is the fifth-most deadly cancer in women in the United States with 60% of cases already metastasized at the time of diagnosis. Multiple screening programs have been attempted, but none so far have demonstrated survival benefit. This project, led by the brilliant team of doctors Rakow-Penner, Dale and McHale at UC San Diego, will develop a robust screening technique, based on advanced diffusion-weighted MRI, that can non-invasively image ovarian cancers. This will decrease the need for surgical removal of ovaries from at risk women while offering the promise of novel screening technique for early detection and treatment for all women.

“Our project, my passion, is to develop an innovative and advanced MRI protocol specifically tailored to detecting ovarian cancer in its earliest stages. By harnessing the power of cutting-edge technology, we aim to provide the information to at risk women so they can make informed decisions about their health and specifically about the very difficult decision they face with respect to prophylactic surgery. With the support of Curebound, we aim to significantly improve the outcomes for women facing this formidable challenge.”
- Rebecca Rakow-Penner, MD, PhD
UC San Diego Health

View the full Press Release about the 2023 Cure Prize

Read the 2023 Research Portfolio

Curebound

INSTITUTIONAL RESEARCH
PARTNERS

Curebound funds innovative, collaborative research between these six cancer research centers in San Diego.

undefined undefined
undefined undefined
undefined undefined
undefined undefined
undefined undefined
undefined undefined

RESOURCES

Curebound 2023 Annual Report undefined

Curebound 2023 Annual Report

2023 Research Portfolio undefined

2023 Research Portfolio

Curebound Giving Circles undefined

Curebound Giving Circles

Director, Research and Impact Job Description undefined

Director, Research and Impact Job Description

Curebound 2023 Video  undefined

Curebound 2023 Video

Curebound Partnerships  undefined

Curebound Partnerships

Curebound Equity Grant RFA undefined

Curebound Equity Grant RFA

Curebound Catalyst Grant RFA undefined

Curebound Catalyst Grant RFA

Curebound Cure Prize RFA undefined

Curebound Cure Prize RFA

Targeted Grant RFA undefined

Targeted Grant RFA

Discovery Grant RFA undefined

Discovery Grant RFA

Curebound Discovery Grant - COMPRENDO Overview undefined

Curebound Discovery Grant - COMPRENDO Overview

Accounting Manager Job Description undefined

Accounting Manager Job Description

Curebound 990 undefined

Curebound 990

Curebound W9 undefined

Curebound W9

Curebound 501(c)(3) undefined

Curebound 501(c)(3)

DIY Printable Resources undefined

DIY Printable Resources

Curebound

EXPLORATION

Curebound
Curebound

ACCELERATION

Curebound
Curebound

COLLABORATION

Curebound
Curebound

CURES